Morgan Stanley Downgrades Baxter Intl to Equal-Weight, Announces $55 Price Target
Morgan Stanley analyst Cecilia Furlong downgrades Baxter Intl (NYSE:BAX) from Overweight to Equal-Weight and announces $55 price target.
Raymond James Downgrades Baxter Intl to Market Perform
Raymond James analyst Jayson Bedford downgrades Baxter Intl (NYSE:BAX) from Outperform to Market Perform.
B of A Securities Downgrades Baxter Intl to Neutral, Announces $55 Price Target
B of A Securities analyst Travis Steed downgrades Baxter Intl (NYSE:BAX) from Buy to Neutral and announces $55 price target.
Wells Fargo Maintains Equal-Weight on Baxter Intl, Lowers Price Target to $57
Wells Fargo analyst Larry Biegelsen maintains Baxter Intl (NYSE:BAX) with a Equal-Weight and lowers the price target from $59 to $57.
Analyst Ratings for Baxter Intl
Within the last quarter, Baxter Intl (NYSE:BAX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
Benzinga’s Top Ratings Upgrades, Downgrades For December 12, 2022
Upgrades For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral to Buy. Colliers…
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Baxter Recalls WatchCare Incontinence Management System, Due To Interference Risk
The FDA classified Baxter International Inc’s (NYSE:BAX) recall of hospital bed systems as the most serious type of concern that it…
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 236 companies set new 52-week lows.